Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 4A (Sema4a) Peptid
Sema4a
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle Sema4a Produkte
- Sema4a (Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 4A (Sema4a))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Verwendungszweck
- SEMAB
- Sequenz
- Peptide (C)KELNKETSRW TTYRG, correspond ing to amino acid residues 355 - 369 of human Semaphorin 4A (Accession Q9H3S1).
- Produktmerkmale
- A Blocking peptide for Anti-Semaphorin 4A (SEMA4A) (extracellular) Antibody (ABIN7043610, ABIN7045300 and ABIN7045301)).
- Reinheit
- >70 %
-
-
- Applikationshinweise
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
- Kommentare
-
Confirmed by amino acid analysis and mass spectrometry.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- 100 μL double distilled water (DDW).
- Konzentration
- 0.4 mg/mL
- Lagerung
- RT,-20 °C
- Informationen zur Lagerung
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
- Target
- Sema4a (Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 4A (Sema4a))
- Synonyme
- SEMA4A Peptide, CORD10 Peptide, RP35 Peptide, SEMAB Peptide, SEMB Peptide, AI132332 Peptide, SemB Peptide, Semab Peptide, semaphorin 4A Peptide, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A Peptide, SEMA4A Peptide, sema4a Peptide, Sema4a Peptide
-
Sie sind hier:
